Youngy Health , Ltd. EBIT

Youngy Health , Ltd. (300247.SZ) currently reports a EBIT of $160M as of September 2026. That compares with $140M in the prior-year period — up 12.8% year over year. That is below the sector sector average of $2.6T. Use the charts on this page to explore Youngy Health , Ltd.'s EBIT history and peer comparisons.

Youngy Health , Ltd.'s EBIT increased from $140M to $160M — a 12.8% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Youngy Health , Ltd.'s EBIT of $160M is lower than the its sector sector average of $2.6T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Youngy Health , Ltd. reported $160M in EBIT as of September 2026. That compares with $140M in the prior-year period — up 12.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $160M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $2.6T. From there, open related valuation or income-statement pages for Youngy Health , Ltd., and consider following 300247.SZ for alerts when major investors trade the stock.